Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | February 16, 2024 01:31pm

Gainers

  • OneMedNet (NASDAQ:ONMD) shares rose 91.2% to $1.44 during Friday's regular session. The market value of their outstanding shares is at $46.4 million.
  • Applied Therapeutics (NASDAQ:APLT) stock increased by 28.53% to $4.82. The market value of their outstanding shares is at $372.2 million.
  • Modular Medical (NASDAQ:MODD) stock moved upwards by 24.58% to $1.56. The company's market cap stands at $34.2 million. As per the press release, Q3 earnings came out 3 days ago.
  • Prelude Therapeutics (NASDAQ:PRLD) shares moved upwards by 23.27% to $4.29. The company's market cap stands at $235.2 million.
  • Ocugen (NASDAQ:OCGN) shares rose 21.98% to $0.91. The company's market cap stands at $233.4 million.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) shares moved upwards by 19.56% to $8.25. The company's market cap stands at $472.3 million.

Losers

  • AMN Healthcare Services (NYSE:AMN) shares declined by 18.9% to $63.0 during Friday's regular session. The company's market cap stands at $2.3 billion. The company's, Q4 earnings came out yesterday.
  • Cross Country Healthcare (NASDAQ:CCRN) stock declined by 14.52% to $18.16. The market value of their outstanding shares is at $638.5 million.
  • Inventiva (NASDAQ:IVA) stock decreased by 13.02% to $3.43. The market value of their outstanding shares is at $176.9 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares declined by 11.84% to $2.4. The company's market cap stands at $10.3 million.
  • T2 Biosystems (NASDAQ:TTOO) shares decreased by 11.74% to $5.64. The market value of their outstanding shares is at $22.8 million. As per the press release, Q4 earnings came out yesterday.
  • Pacific Biosciences (NASDAQ:PACB) shares declined by 11.63% to $5.89. The market value of their outstanding shares is at $1.5 billion. The company's, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AMN APLT CCRN HCTI IVA MODD OCGN ONMD PACB PHAT PRLD TTOO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist